Aardvark Therapeutics Inc. Common Stock
AARD | NASDAQ
$5.65
+$0.08 (+1.44%)
Sep 22, 2026, 12:55 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -69.89M | -69.87M | -57.59M | -48.77M | -36.64M | -27.72M | -20.59M | -13.85M | -11.78M | -6.33M | -4.15M | -2.11M |
Depreciation & Amortization | -87K | -718K | -595K | -726K | -649K | 19K | 16K | 162K | 101K | 53K | 51K | 26K |
Stock-Based Compensation | 3.95M | 2.64M | 867K | 1.04M | 1.19M | 605K | 439K | 335K | 262K | 208K | 141K | 72K |
Other Working Capital | -813K | 1.42M | 117K | -1.96M | -1.09M | -2.36M | 775K | 915K | 167K | -372K | -498K | -260K |
Other Non-Cash Items | 397K | 2.86M | 2.79M | -862K | 441K | 276K | 473K | 385K | 1.04M | 1.08M | 839K | 742K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | -3.78M | 3.44M | 356K | 1.84M | 2.75M | -465K | 1.57M | 1.45M | 1.23M | 59K | 378K | -316K |
Operating Cash Flow | -69.41M | -61.65M | -54.17M | -47.48M | -32.91M | -27.29M | -18.09M | -11.52M | -9.15M | -4.93M | -2.74M | -1.59M |
Capital Expenditures | -4K | -95K | -95K | -101K | -102K | -104K | -109K | -103K | -98K | -5K | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -4.95M | -4.95M | -129.6M | -124.65M | -124.65M | -124.65M | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 121.5M | 102.25M | 80.03M | 50.78M | 21.53M | 12.03M | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | -11.89M | -11.89M | -11.89M | -11.89M | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | 116.55M | 97.21M | -49.67M | -85.86M | -115.12M | -124.62M | -12M | -103K | -98K | -5K | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | -1.18M | -1.11M | 81.83M | 81.83M | 83.01M | 82.94M | n/a | n/a | n/a |
Financial Cash Flow | 711K | 378K | 89.25M | 90.35M | 87.85M | 170.87M | 81.99M | 83.01M | 82.94M | n/a | n/a | n/a |
Net Cash Flow | 47.85M | 35.93M | -14.59M | -42.99M | -60.18M | 18.96M | 51.91M | 71.39M | 73.7M | -4.94M | -2.74M | -1.59M |
Free Cash Flow | -69.41M | -61.75M | -54.27M | -47.58M | -33.02M | -27.39M | -18.2M | -11.62M | -9.24M | -4.94M | -2.74M | -1.59M |
Adj. Free Cash Flow | -73.37M | -64.39M | -55.13M | -48.62M | -34.2M | -27.99M | -18.64M | -11.95M | -9.51M | -5.14M | -2.88M | -1.66M |
Maintenance CapEx | -4K | -95K | -95K | -101K | -102K | -59K | -61K | -55K | -50K | n/a | n/a | n/a |
Growth CapEx | n/a | n/a | n/a | n/a | n/a | -45K | -48K | -48K | -48K | n/a | n/a | n/a |
Owner Earnings | -69.41M | -61.75M | -54.27M | -47.58M | -33.02M | -27.34M | -18.15M | -11.57M | -9.2M | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove AARD